Cargando…

Multi-trajectories of lipid indices with incident cardiovascular disease, heart failure, and all-cause mortality: 23 years follow-up of two US cohort studies

BACKGROUND: Understanding the distinct patterns (trajectories) of variation in blood lipid levels before diagnosing cardiovascular disease (CVD) might carry important implications for improving disease prevention or treatment. METHODS: We investigated 14,373 participants (45.5% men) aged 45–84 from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koohi, Fatemeh, Khalili, Davood, Mansournia, Mohammad Ali, Hadaegh, Farzad, Soori, Hamid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254336/ https://www.ncbi.nlm.nih.gov/pubmed/34217318 http://dx.doi.org/10.1186/s12967-021-02966-4

Ejemplares similares

Longitudinal effects of lipid indices on incident cardiovascular diseases adjusting for time-varying confounding using marginal structural models: 25 years follow-up of two US cohort studies
por: Koohi, Fatemeh, et al.
Publicado: (2022)

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2021)

Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2018)

Optimal cut-points of different anthropometric indices and their joint effect in prediction of type 2 diabetes: results of a cohort study
por: Zafari, Neda, et al.
Publicado: (2018)

Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
por: Sardarinia, Mahsa, et al.
Publicado: (2021)

External validation of the American prediction model for incident type 2 diabetes in the Iranian population
por: Asgari, Samaneh, et al.
Publicado: (2023)

Patterns of change in obesity indices and other cardiometabolic risk factors before the diagnosis of type 2 diabetes: two decades follow-up of the Tehran lipid and glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2022)

Performance of Stepwise Screening Methods in Identifying Individuals at High Risk of Type 2 Diabetes in an Iranian Population
por: Lotfaliany, Mojtaba, et al.
Publicado: (2021)

Sex Specific Incidence Rates of Type 2 Diabetes and Its Risk Factors over 9 Years of Follow-Up: Tehran Lipid and Glucose Study
por: Derakhshan, Arash, et al.
Publicado: (2014)

Risk of Coronary Heart Events Based on Rose Angina Questionnaire and ECG Besides Diabetes and Other Metabolic Risk Factors: Results of a 10-Year Follow-up in Tehran Lipid and Glucose Study
por: Mansournia, Mohammad Ali, et al.
Publicado: (2017)

The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study
por: Hadaegh, Farzad, et al.
Publicado: (2021)

Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study
por: Masudi, Sima, et al.
Publicado: (2015)

Impact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes: Tehran lipid and glucose study
por: Khaloo, Pegah, et al.
Publicado: (2018)

Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2020)

Correction To: Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2020)

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study
por: Asgari, Samaneh, et al.
Publicado: (2022)

Anthropometric Indices as Predictors of Coronary Heart Disease Risk: Joint Modeling of Longitudinal Measurements and Time to Event
por: GILANI, Neda, et al.
Publicado: (2017)

Knowledge, Attitude, and Practice Regarding Cardiovascular Diseases in Adults Attending Health Care Centers in Tehran, Iran
por: Koohi, Fatemeh, et al.
Publicado: (2020)

External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population
por: Asgari, Samaneh, et al.
Publicado: (2020)

A new look at risk patterns related to coronary heart disease incidence using survival tree analysis: 12 Years Longitudinal Study
por: Ramezankhani, Azra, et al.
Publicado: (2017)

Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2016)

Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study
por: Toreyhi, Hossein, et al.
Publicado: (2021)

World Bank Income Group, Health Expenditure or Cardiometabolic Risk Factors? A Further Explanation of the Wide Gap in Cardiometabolic Mortality Between Worldwide Countries: An Ecological Study
por: Lotfaliany, Mojtaba, et al.
Publicado: (2018)

Determining the Factors Associated with Cardiovascular Disease Recurrence: Tehran Lipid and Glucose Study
por: Taravatmanesh, Samira, et al.
Publicado: (2017)

Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2018)

Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2016)

Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2019)

12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study
por: Rabani, SeyedHossein, et al.
Publicado: (2018)

Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East population
por: Hatami, Masumeh, et al.
Publicado: (2012)

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study
por: Rasooli, Rahele, et al.
Publicado: (2022)

Adjusting for reverse causation to estimate the effect of obesity on mortality after incident heart failure in the Atherosclerosis Risk in Communities (ARIC) study
por: Shakiba, Maryam, et al.
Publicado: (2016)

Long-term effectiveness of a lifestyle intervention on the prevention of type 2 diabetes in a middle-income country
por: Lotfaliany, Mojtaba, et al.
Publicado: (2020)

Prediction Models for Type 2 Diabetes Risk in the General Population: A Systematic Review of Observational Studies
por: Asgari, Samaneh, et al.
Publicado: (2021)

Letter to the Editor Regarding “Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study”
por: Asgari, Samaneh, et al.
Publicado: (2021)

Diabetes, Hypertension, and Incidence of Chronic Kidney Disease: Is There any Multiplicative or Additive Interaction?
por: Erfanpoor, Saeed, et al.
Publicado: (2020)

Impact of 3-year changes in fasting insulin and insulin resistance indices on incident hypertension: Tehran lipid and glucose study
por: Baghbani-Oskouei, Aidin, et al.
Publicado: (2019)

The Incidence of Coronary Heart Disease and the Population Attributable Fraction of Its Risk Factors in Tehran: A 10-Year Population-Based Cohort Study
por: Khalili, Davood, et al.
Publicado: (2014)

The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies
por: Deravi, Niloofar, et al.
Publicado: (2023)

Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS)
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2bo4eqaddeo7pbou7bbmt34ve2